![National Center for Advancing and Translational Sciences](https://rarediseases.info.nih.gov/content/images/NCATS_Logo.png)
![Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences](https://rarediseases.info.nih.gov/content/images/GARD_logo.png)
List of FDA Orphan Drugs
GARD has information from the Food and Drug Administration (FDA) on treatments approved for rare diseases, known as orphan products/drugs. The Orphan Drug Act was passed in 1983 to give drug companies incentives to develop treatments for rare diseases. The FDA Office of Orphan Products Development determines if a drug qualifies as an orphan product. The following information comes from the FDA database of orphan drug designations and approvals. You can output the data into an Excel spreadsheet from the FDA website. More information on orphan drug development is available from Global Genes and Orphanet.
![pills fda orphan drugs](https://rarediseases.info.nih.gov/content/images/pills-fda-orphan-drugs.jpg)
D
- Dermatofibrosarcoma protuberans
- Diffuse gastric cancer
- Diffuse Large B-Cell Lymphoma
- Digestive System Melanoma
- Disseminated infection with mycobacterium avium complex
- Dopamine beta hydroxylase deficiency
- Dravet syndrome
- Duchenne muscular dystrophy
- Duodenal carcinoid syndrome
- Dystonia 2, torsion, autosomal recessive
- DYT-TOR1A
No hay comentarios:
Publicar un comentario